Travel Vaccines Market Trends, Drivers, Growth Opportunities, Challenges, and Investment Opportunities
The global travel vaccines market is driven by increasing international tourism and favorable government initiatives promoting the benefits of vaccination.
(EMAILWIRE.COM, July 23, 2019 ) According to the latest report by IMARC Group, titled “Travel Vaccines Market Research Report and Forecast 2019-2024”, the global travel vaccines market size reached US$ 4.9 Billion in 2018. Travel vaccines are immunization shots that travelers can get before traveling to other parts of the world where there is a high risk of developing certain diseases. These vaccines build immunity against viral and microbial invasions while improving the overall health of the individual. They introduce the disease-causing microbes into the bloodstream to help the human body develop antibodies to fight off the same, if exposed to in the future. These shots must be taken at least 4 to 6 weeks before traveling as this gives enough time for the immunization to start working efficiently.
Request For Free Sample Pdf Copy @ https://www.imarcgroup.com/travel-vaccines-market/requestsample
Global Travel Vaccines Market Trends:
Rising occurrence of infectious and travel-related diseases such as Japanese encephalitis, diphtheria, meningitis and yellow fever is one of the major factors that are driving the growth of the market. In addition to this, owing to factors such as the rising globalization and reduced international airfares, there has been an increase in international tourism. Consequently, the sales of travel vaccines have also witnessed a significant rise across the globe. Apart from this, several combination vaccines are also available for travelers, which protect against more than one disease. They are widely gaining popularity amongst the users as they reduce the number of vaccines required. Furthermore, government bodies in several countries are investing in promoting the use of these vaccines. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases such as cholera, polio, typhoid and hepatitis A in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.1 billion by 2024, growing at a CAGR of around 9% during 2019-2024.
Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/travel-vaccines-market
Insights on Market Segmentation:
Market Breakup by Composition:
1. Mono Vaccines
2. Combination Vaccines
On the basis of the composition, the market has been bifurcated into mono vaccines and combination vaccines, wherein combination vaccines are the most preferred segment.
Market Breakup by Disease:
1. Hepatitis A
2. DPT
3. Yellow Fever
4. Typhoid
5. Hepatitis B
6. Measles and Mumps
7. Rabies
8. Meningococcal
9. Varicella
10. Japanese Encepthalitis
11. Others
Based on the disease, the market has been divided into hepatitis A, hepatitis B, Japanese encephalitis, DPT, meningococcal, rabies, typhoid, yellow fever, measles and mumps, varicella, and others. Amongst these, hepatitis A exhibits a clear dominance in the market.
Market Breakup by Region:
1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America
On the geographical front, North America holds the leading position in the market, accounting for the majority of the overall market share. The other major regions include Europe, Asia Pacific, Middle East and Africa and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been studied in the report with some of the major players operating in the market being GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, ALK-Abelló, Bavarian Nordic, Crucell N.V., CSL Limited, MedImmune, LLC, Altimmune, Abbott Laboratories and F. Hoffman-La Roche Ltd.
Browse similar reports by IMARC Group:
Glioblastoma Multiforme Treatment Market Research Report and Forecast: https://www.imarcgroup.com/glioblastoma-multiforme-treatment-market
Pain Management Drugs Market Research Report and Forecast: https://www.imarcgroup.com/pain-management-drugs-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Request For Free Sample Pdf Copy @ https://www.imarcgroup.com/travel-vaccines-market/requestsample
Global Travel Vaccines Market Trends:
Rising occurrence of infectious and travel-related diseases such as Japanese encephalitis, diphtheria, meningitis and yellow fever is one of the major factors that are driving the growth of the market. In addition to this, owing to factors such as the rising globalization and reduced international airfares, there has been an increase in international tourism. Consequently, the sales of travel vaccines have also witnessed a significant rise across the globe. Apart from this, several combination vaccines are also available for travelers, which protect against more than one disease. They are widely gaining popularity amongst the users as they reduce the number of vaccines required. Furthermore, government bodies in several countries are investing in promoting the use of these vaccines. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases such as cholera, polio, typhoid and hepatitis A in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.1 billion by 2024, growing at a CAGR of around 9% during 2019-2024.
Browse full report with detailed TOC and list of figures and tables: https://www.imarcgroup.com/travel-vaccines-market
Insights on Market Segmentation:
Market Breakup by Composition:
1. Mono Vaccines
2. Combination Vaccines
On the basis of the composition, the market has been bifurcated into mono vaccines and combination vaccines, wherein combination vaccines are the most preferred segment.
Market Breakup by Disease:
1. Hepatitis A
2. DPT
3. Yellow Fever
4. Typhoid
5. Hepatitis B
6. Measles and Mumps
7. Rabies
8. Meningococcal
9. Varicella
10. Japanese Encepthalitis
11. Others
Based on the disease, the market has been divided into hepatitis A, hepatitis B, Japanese encephalitis, DPT, meningococcal, rabies, typhoid, yellow fever, measles and mumps, varicella, and others. Amongst these, hepatitis A exhibits a clear dominance in the market.
Market Breakup by Region:
1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America
On the geographical front, North America holds the leading position in the market, accounting for the majority of the overall market share. The other major regions include Europe, Asia Pacific, Middle East and Africa and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been studied in the report with some of the major players operating in the market being GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, ALK-Abelló, Bavarian Nordic, Crucell N.V., CSL Limited, MedImmune, LLC, Altimmune, Abbott Laboratories and F. Hoffman-La Roche Ltd.
Browse similar reports by IMARC Group:
Glioblastoma Multiforme Treatment Market Research Report and Forecast: https://www.imarcgroup.com/glioblastoma-multiforme-treatment-market
Pain Management Drugs Market Research Report and Forecast: https://www.imarcgroup.com/pain-management-drugs-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Information:
IMARC Services Pvt. Ltd.
Richard Lewis
Tel: 6317911145
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
IMARC Services Pvt. Ltd.
Richard Lewis
Tel: 6317911145
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results